Thursday, April 25, 2024 Apr 25, 2024
75° F Dallas, TX
Advertisement
Coronavirus

COVID-19 Bulletin (11/18/21)

Pfizer wants FDA approval for its COVID-19 pill and Fair Park will open a vaccination site later this month.
|
Image

Dallas County Judge Clay Jenkins reported 308 new COVID-19 cases and 15 deaths on Wednesday.


Pfizer asks FDA for authorization of their experimental COVID-19 pill, The Dallas Morning News reports. Pfizer is requesting that the drug be made available for high-risk adults who have mild-to-moderate COVID-19 infections. Pfizer’s pill has been shown to cut the rate of hospitalizations and deaths among people with coronavirus infections by nearly 90%.


A CDC panel is set to discuss expanding booster eligibility Friday, reports the U.S. News & World Report. This CDC advisory panel will discuss expanding eligibility of COVID-19 booster shots to all adults. Some cities and states already allow all adults to get boosters, but it is not official U.S. policy. This discussion could make shots available across the nation as early as next weekend.


Fair Park set to reopen vaccination site later this month, NBC DFW reports.  Dallas County Health and Human Services (DCHHS) is reopening the Fair Park COVID-19 vaccination location starting Nov. 21. Pfizer, Moderna, and Johnson & Johnson vaccines will be available for all three doses, as well as doses for children ages 5-11.

Related Articles

Image
Arts & Entertainment

VideoFest Lives Again Alongside Denton’s Thin Line Fest

Bart Weiss, VideoFest’s founder, has partnered with Thin Line Fest to host two screenings that keep the independent spirit of VideoFest alive.
Image
Local News

Poll: Dallas Is Asking Voters for $1.25 Billion. How Do You Feel About It?

The city is asking voters to approve 10 bond propositions that will address a slate of 800 projects. We want to know what you think.
Image
Basketball

Dallas Landing the Wings Is the Coup Eric Johnson’s Committee Needed

There was only one pro team that could realistically be lured to town. And after two years of (very) middling results, the Ad Hoc Committee on Professional Sports Recruitment and Retention delivered.
Advertisement